Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thalmann

Showing results (41-50 of 307) with videos related to

Pageof 31
Sort By:
The American Journal of Surgical Pathology|February 15, 2014
Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survivalAchim Fleischmann, George N Thalmann, Aurel Perren, et al.
Swiss Medical Weekly|May 7, 2009
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancerC A Rentsch, M G Cecchini, G N Thalmann
European Urology Oncology|May 18, 2019
Lessons Learned by Pushing the Limits?George N Thalmann, Patrick Y Wuethrich, Fiona C Burkhard
Molecular and Cellular Endocrinology|February 8, 2011
High expression of NPY receptors in the human testisMeike Körner, Beatriche Waser, George N Thalmann, et al.
Journal of Clinical Pathology|April 6, 2010
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancerRoland Seiler, Michael von Gunten, George N Thalmann, et al.
The Journal of Urology|September 28, 2002
Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgeryGeorge N Thalmann, Regula Markwalder, Bernhard Walter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factorAchim Fleischmann, George N Thalmann, Regula Markwalder, et al.
The Journal of Urology|September 25, 1997
Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progressionG N Thalmann, B Dewald, M Baggiolini, et al.
Human Pathology|August 13, 2011
High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patientsRoland Seiler, Michael von Gunten, George N Thalmann, et al.
The American Journal of Surgical Pathology|December 23, 2004
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladderAchim Fleischmann, George N Thalmann, Regula Markwalder, et al.
Pageof 31

Showing results (41-50 of 307) with videos related to

Sort By:
Pageof 31
The American Journal of Surgical Pathology|February 15, 2014
Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survivalAchim Fleischmann, George N Thalmann, Aurel Perren, et al.
Swiss Medical Weekly|May 7, 2009
Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancerC A Rentsch, M G Cecchini, G N Thalmann
European Urology Oncology|May 18, 2019
Lessons Learned by Pushing the Limits?George N Thalmann, Patrick Y Wuethrich, Fiona C Burkhard
Molecular and Cellular Endocrinology|February 8, 2011
High expression of NPY receptors in the human testisMeike Körner, Beatriche Waser, George N Thalmann, et al.
Journal of Clinical Pathology|April 6, 2010
Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancerRoland Seiler, Michael von Gunten, George N Thalmann, et al.
The Journal of Urology|September 28, 2002
Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgeryGeorge N Thalmann, Regula Markwalder, Bernhard Walter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factorAchim Fleischmann, George N Thalmann, Regula Markwalder, et al.
The Journal of Urology|September 25, 1997
Interleukin-8 expression in the urine after bacillus Calmette-Guerin therapy: a potential prognostic factor of tumor recurrence and progressionG N Thalmann, B Dewald, M Baggiolini, et al.
Human Pathology|August 13, 2011
High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patientsRoland Seiler, Michael von Gunten, George N Thalmann, et al.
The American Journal of Surgical Pathology|December 23, 2004
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladderAchim Fleischmann, George N Thalmann, Regula Markwalder, et al.
Pageof 31